Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar zhilmi (< 20) Submitted: 1/28/2010 11:24:14 PM : Outperform Start Price: $18.01 MYL Score: -1.05

Generics, nice line of meds, improving stats

Featured Broker Partners


Advertisement